Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated?: A survey of the literature from 2002 to 2004

被引:150
作者
Brendel, Karl
Dartois, Celine
Comets, Emmanuelle
Lemenuel-Diot, Annabelle
Laveille, Christian
Tranchand, Brigitte
Girard, Pascal
Laffont, Celine M.
Mentre, France
机构
[1] INSERM, U738, F-75018 Paris, France
[2] Univ Paris 07, Paris, France
[3] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France
[4] Univ Lyon 1, CTO, Fac Med Lyon Sud, EA 3738, Oullins, France
[5] Inst Rech Int Servier, F-92415 Courbevoie, France
[6] Exprimo NV, Lummen, Belgium
[7] Ctr Leon Berard, F-69373 Lyon, France
[8] INSERM, F-69008 Lyon, France
关键词
D O I
10.2165/00003088-200746030-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Model evaluation is an important issue in population analyses. We aimed to perform a systematic review of all population pharmacokinetic and/or pharmacodynamic analyses published between 2002 and 2004 to survey the current methods used to evaluate models and to assess whether those models were adequately evaluated. We selected 324 articles in MEDLINE using defined key words and built a data abstraction form composed of a checklist of items to extract the relevant information from these articles with respect to model evaluation. In the data abstraction form, evaluation methods were divided into three subsections: basic internal methods (goodness-of-fit [GOF] plots, uncertainty in parameter estimates and model sensitivity), advanced internal methods (data splitting, resampling techniques and Monte Carlo simulations) and external model evaluation. Basic internal evaluation was the most frequently described method in the reports: 65% of the models involved GOF evaluation. Standard errors or confidence intervals were reported for 50% of fixed effects but only for 22% of random effects. Advanced internal methods were used in approximately 25% of models: data splitting was more often used than bootstrap and cross-validation; simulations were used in 6% of models to evaluate models by a visual predictive check or by a posterior predictive check. External evaluation was performed in only 7% of models. Using the subjective synthesis of model evaluation for each article, we judged the models to be adequately evaluated in 28% of pharmacokinetic models and 26% of pharmacodynamic models. Basic internal evaluation was preferred to more advanced methods, probably because the former is performed easily with most software. We also noticed that when the aim of modelling was predictive, advanced internal methods or more stringent methods were more often used.
引用
收藏
页码:221 / 234
页数:14
相关论文
共 55 条
[1]   Role of modelling and simulation in Phase I drug development [J].
Aarons, L ;
Karlsson, MO ;
Mentré, F ;
Rombout, F ;
Steimer, JL ;
van Peer, A .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :115-122
[2]   Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction [J].
Ambrose, PG ;
Bhavnani, SM ;
Cirincione, BB ;
Piedmonte, M ;
Grasela, TH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (03) :435-440
[3]  
[Anonymous], 2021, Bayesian Data Analysis
[4]   THE ANALYSIS OF REPEATED-MEASURES DATA ON SCHIZOPHRENIC REACTION-TIMES USING MIXTURE-MODELS [J].
BELIN, TR ;
RUBIN, DB .
STATISTICS IN MEDICINE, 1995, 14 (08) :747-768
[5]   Population pharmacokinetics of APOMINE™:: A meta-analysis in cancer patients and healthy males [J].
Bonate, PL ;
Floret, S ;
Bentzen, C .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (02) :142-155
[6]  
BOUTRON I, 2003, J AM STAT ASSOC, V290, P1060
[7]  
BRENDEL K, DATA ABSTRACTION POP
[8]   The pharmacokinetics and cardiovascular effects of a single intravenous dose of protamine in normal volunteers [J].
Butterworth, J ;
Lin, YA ;
Prielipp, R ;
Bennett, J ;
James, R .
ANESTHESIA AND ANALGESIA, 2002, 94 (03) :514-522
[9]   Clinical trial simulation using therapeutic effect modeling: Application to ivabradine efficacy in patients with angina pectoris [J].
Chabaud, S ;
Girard, P ;
Nony, P ;
Boissel, JP .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2002, 29 (04) :339-363
[10]  
COHEN L, 1960, COEFFICIENT AGREEMEN, P37